Nxera Pharma Co., Ltd.
4565.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥1,672 | -¥2,377 | -¥760 | -¥1,335 |
| Dep. & Amort. | ¥1,106 | ¥1,095 | ¥1,082 | ¥1,003 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥371 |
| Change in WC | -¥1,173 | -¥915 | ¥324 | -¥7,228 |
| Other Non-Cash | -¥1,237 | ¥2,017 | -¥33 | -¥3,781 |
| Operating Cash Flow | -¥2,976 | -¥180 | ¥613 | -¥10,970 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥105 | -¥90 | -¥262 | -¥153 |
| Net Acquisitions | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Purchases | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Sales/Matur. | ¥43 | ¥9 | ¥3,841 | ¥0 |
| Other Inv. Act. | ¥13 | -¥1 | ¥18 | -¥4,791 |
| Investing Cash Flow | -¥49 | -¥82 | ¥3,597 | -¥4,944 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥1,450 | -¥1,450 | -¥1,450 | -¥1,300 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | ¥0 |
| Dividends Paid | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Fin. Act. | -¥224 | -¥227 | -¥223 | -¥374 |
| Financing Cash Flow | -¥1,674 | -¥1,677 | -¥1,673 | -¥1,674 |
| Forex Effect | ¥163 | ¥471 | -¥340 | ¥988 |
| Net Chg. in Cash | -¥4,536 | -¥1,468 | ¥2,197 | -¥16,600 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥32,997 | ¥34,465 | ¥32,268 | ¥48,868 |
| End Cash | ¥28,461 | ¥32,997 | ¥34,465 | ¥32,268 |
| Free Cash Flow | -¥3,078 | -¥270 | ¥504 | -¥11,123 |